{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T19:40:18Z","timestamp":1771011618030,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1124\/dmd.32.11.1304","type":"journal-article","created":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T20:36:07Z","timestamp":1568234167000},"page":"1304-1310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA"],"prefix":"10.1016","volume":"32","author":[{"given":"Margarida F.B.","family":"Silva","sequence":"first","affiliation":[]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[]},{"given":"Paul","family":"Allers","sequence":"additional","affiliation":[]},{"given":"Cornelis","family":"Jakobs","sequence":"additional","affiliation":[]},{"given":"Marinus","family":"Duran","sequence":"additional","affiliation":[]},{"given":"Isabel Tavares","family":"de Almeida","sequence":"additional","affiliation":[]},{"given":"Ronald J.A.","family":"Wanders","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1124\/dmd.32.11.1304_bib1","series-title":"Valproate (Milestones in Drug Therapy)","first-page":"47","article-title":"Chemistry and biotransformation","author":"Abbott","year":"1999"},{"key":"10.1124\/dmd.32.11.1304_bib2","series-title":"Cellular Energy Metabolism and Its Regulation.","author":"Atkinson","year":"1977"},{"key":"10.1124\/dmd.32.11.1304_bib3","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1046\/j.1432-1033.2003.03470.x","article-title":"2-Oxo acid dehydrogenase complexes in redox regulation.","volume":"270","author":"Bunik","year":"2003","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.32.11.1304_bib4","doi-asserted-by":"crossref","first-page":"21431","DOI":"10.1074\/jbc.M201708200","article-title":"Complete reconstitution of the human coenzyme A biosynthetic pathway via comparative genomics.","volume":"277","author":"Daugherty","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.32.11.1304_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2165\/00003495-199447020-00008","article-title":"Valproic acid: a reappraisal of its pharmacological properties and clinical efficacy in epilepsy.","volume":"47","author":"Davis","year":"1994","journal-title":"Drugs"},{"key":"10.1124\/dmd.32.11.1304_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0090-9556(24)15353-6","article-title":"Identification and characterization of N-acetylcysteine conjugates of valproic acid in humans and animals.","volume":"28","author":"Gopaul","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.11.1304_bib7","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1124\/dmd.31.1.114","article-title":"Amino acid conjugates: metabolites of 2-propylpentanoic acid (valproic acid) in epileptic patients.","volume":"31","author":"Gopaul","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.32.11.1304_bib8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1055\/s-2007-973560","article-title":"Altered antioxidant enzyme activities in children with a serious adverse experience related to valproic acid therapy.","volume":"29","author":"Graf","year":"1998","journal-title":"Neuropediatrics"},{"key":"10.1124\/dmd.32.11.1304_bib9","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/00498258409151426","article-title":"Aspects of the metabolism of valproic acid.","volume":"14","author":"Granneman","year":"1984","journal-title":"Xenobiotica"},{"key":"10.1124\/dmd.32.11.1304_bib10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0304-4165(90)90079-C","article-title":"The enzymatic basis for the metabolism and inhibitory effects of valproic acid: dehydrogenation of valproyl-CoA by 2-methyl-branched-chain acyl-CoA dehydrogenase.","volume":"1034","author":"Ito","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/dmd.32.11.1304_bib11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0009-2797(94)90014-0","article-title":"Metabolic activation of unsaturated derivatives of valproic acid. Identification of novel glutathione adducts formed through coenzyme A-dependent and -independent processes.","volume":"90","author":"Kassahun","year":"1994","journal-title":"Chem-Biol Interact"},{"key":"10.1124\/dmd.32.11.1304_bib12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1528-1157.1999.tb00814.x","article-title":"Fatal liver failure associated with valproate therapy in a patient with Friedreich\u2019s disease: review of valproate hepatotoxicity in adults.","volume":"40","author":"K\u00f6nig","year":"1999","journal-title":"Epilepsia"},{"key":"10.1124\/dmd.32.11.1304_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1528-1157.1994.tb02546.x","article-title":"Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities.","volume":"35","author":"K\u00f6nig","year":"1994","journal-title":"Epilepsia"},{"key":"10.1124\/dmd.32.11.1304_bib14","doi-asserted-by":"crossref","first-page":"7171","DOI":"10.1016\/S0021-9258(19)43375-9","article-title":"Regulation of glutamate metabolism and interactions with the citric acid cycle in rat heart mitochondria.","volume":"248","author":"LaNoue","year":"1973","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.32.11.1304_bib15","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1021\/bi00216a012","article-title":"Mitochondrial metabolism of valproic acid.","volume":"30","author":"Li","year":"1991","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.32.11.1304_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0378-4347(00)84207-3","article-title":"Valproic acid and several metabolites: quantitative determination in serum, urine, breast milk and tissues by gas chromatography-mass spectrometry using selected ion monitoring.","volume":"226","author":"Nau","year":"1981","journal-title":"J Chromatogr"},{"key":"10.1124\/dmd.32.11.1304_bib17","doi-asserted-by":"crossref","first-page":"12659","DOI":"10.1021\/bi980949m","article-title":"Thermodynamics of ligand binding and catalysis in human liver medium-chain acyl-CoA dehydrogenase: comparative studies involving normal and 3\u2032-dephosphorylated C8-CoAs and wild type and Asn191\u2192Ala (N191A) mutant enzymes.","volume":"37","author":"Peterson","year":"1998","journal-title":"Biochemistry"},{"key":"10.1124\/dmd.32.11.1304_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj3250751","article-title":"Functional role of a distal (3\u2032-phosphate) group of CoA in the recombinant human liver medium-chain acyl-CoA dehydrogenase-catalysed reaction.","volume":"325","author":"Peterson","year":"1997","journal-title":"Biochem J"},{"key":"10.1124\/dmd.32.11.1304_bib19","series-title":"Milestones in Drug Therapy Valproate","first-page":"91","article-title":"Toxicity","author":"Radatz","year":"1999"},{"key":"10.1124\/dmd.32.11.1304_bib20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1042\/bj2650849","article-title":"Comparison of the binding affinities of acyl-CoA-binding protein and fatty-acid-binding protein for long-chain acyl-CoA esters.","volume":"265","author":"Rasmussen","year":"1990","journal-title":"Biochem J"},{"key":"10.1124\/dmd.32.11.1304_bib21","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/bms.1200180308","article-title":"Quantitative metabolic profiling of valproic acid in humans using automated gas chromatographic\/mass spectrometric techniques.","volume":"18","author":"Rettenmeier","year":"1989","journal-title":"Biomed Environ Mass Spectrom"},{"key":"10.1124\/dmd.32.11.1304_bib22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1006\/abio.2000.4947","article-title":"Synthesis and intramitochondrial levels of valproyl-CoA metabolites.","volume":"290","author":"Silva","year":"2001","journal-title":"Anal Biochem"},{"key":"10.1124\/dmd.32.11.1304_bib23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1042\/bj3620755","article-title":"Complete \u03b2-oxidation of valproate: cleavage of 3-oxovalproyl-CoA by a mitochondrial 3-oxoacyl-CoA thiolase.","volume":"362","author":"Silva","year":"2002","journal-title":"Biochem J"},{"key":"10.1124\/dmd.32.11.1304_bib24","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1016\/0006-291X(79)91239-7","article-title":"Mitochondrial biosynthesis of coenzyme A.","volume":"91","author":"Skrede","year":"1979","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/dmd.32.11.1304_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid.","volume":"150","author":"Smith","year":"1985","journal-title":"Anal Biochem"},{"issue":"3A","key":"10.1124\/dmd.32.11.1304_bib26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF01962700","article-title":"Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.","volume":"14","author":"Stephens","year":"1992","journal-title":"Pharm Weekbl Sci"},{"key":"10.1124\/dmd.32.11.1304_bib27","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1021\/tx950120y","article-title":"Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC\/MS\/MS characterization of the GSH-glucuronide diconjugates.","volume":"9","author":"Tang","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1124\/dmd.32.11.1304_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0021-9673(00)96121-1","article-title":"Determination of VPA and its metabolites by GC-MS with SIM.","volume":"399","author":"Tatsuhara","year":"1987","journal-title":"J Chromatogr"},{"key":"10.1124\/dmd.32.11.1304_bib29","series-title":"Biochemistry","first-page":"267","article-title":"Metabolic strategies","author":"Zubay","year":"1998"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624030319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624030319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.32.11.1304","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T17:01:25Z","timestamp":1739898085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624030319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":29,"aliases":["10.1124\/dmd...","10.1124\/dmd..."],"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0090955624030319"],"URL":"https:\/\/doi.org\/10.1124\/dmd.32.11.1304","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"VALPROYL-DEPHOSPHOCoA: A NOVEL METABOLITE OF VALPROATE FORMED IN VITRO IN RAT LIVER MITOCHONDRIA","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.32.11.1304","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2004 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}